Zaleski G X, Funaki B, Kenney S, Lorenz J M, Garofalo R
Racine Radiologist Group, Wisconsin, USA.
J Vasc Interv Radiol. 1999 Feb;10(2 Pt 1):129-36. doi: 10.1016/s1051-0443(99)70454-9.
To evaluate the use of urokinase and angioplasty in treatment of thrombosed Brescia-Cimino fistulas.
From January 1994 to April 1997, 17 patients (10 women and seven men; age range, 17-78 years; mean 54 years) with complete thrombosis of their Brescia-Cimino fistulas were referred to our department for thrombolysis and angioplasty. Thrombosis of the fistula had occurred within 24 hours of attempted thrombolysis in 11 patients and between 24 and 72 hours in six patients. Urokinase was given as a bolus into the fistula, and heparin was administered into the central venous vasculature. Angioplasty was performed at the arterial inflow and the fistula itself.
Procedural success was 82% (14 of 17 patients). Primary patency was 71% at 6 months and 64% at 12 months. Primary assisted patency was 93% at 6 and 12 months. Secondary patency was 100% at 6 and 12 months. One fistula thrombosed within 24 hours of the initial procedure, and a repeat procedure was successfully performed. All other fistulas have remained patent with a maximum follow-up of 40 months (average function of 16 months). Two patients have died of unrelated causes. One Wallstent was deployed for treatment of an angioplasty-induced venous rupture.
Long-term function of Brescia-Cimino fistulas after thrombolysis and angioplasty is excellent with patency rates similar to those of newly placed, mature Brescia-Cimino fistulas.
评估尿激酶和血管成形术在治疗血栓形成的布雷西亚-奇米诺内瘘中的应用。
1994年1月至1997年4月,17例(10例女性和7例男性;年龄范围17 - 78岁,平均54岁)布雷西亚-奇米诺内瘘完全血栓形成的患者被转诊至我科进行溶栓和血管成形术。11例患者在尝试溶栓后24小时内发生瘘管血栓形成,6例患者在24至72小时内发生。将尿激酶推注到瘘管内,并将肝素注入中心静脉血管系统。在动脉流入端和瘘管本身进行血管成形术。
手术成功率为82%(17例患者中的14例)。6个月时的初始通畅率为71%,12个月时为64%。6个月和12个月时的初始辅助通畅率为93%。6个月和12个月时的二次通畅率为100%。1例瘘管在初始手术后24小时内血栓形成,成功进行了重复手术。所有其他瘘管均保持通畅,最长随访40个月(平均功能16个月)。2例患者死于无关原因。1个Wallstent被用于治疗血管成形术引起的静脉破裂。
溶栓和血管成形术后布雷西亚-奇米诺内瘘的长期功能良好,通畅率与新建立的成熟布雷西亚-奇米诺内瘘相似。